Mr. Chair, finally, I note that after we've watched and witnessed Ebola and have been dealing with it, and this connects to TB, it's obviously about the medicines but we also have to have resilience in the health systems.
I want to finish my comments because the chair is going to pull the plug on me. We do understand that when we are funding these initiatives through the Global Fund, it's also about resilience in health systems, allowing people to get the diagnosis as well as the treatment.
Again, thank you to our witnesses.